Net Worth Advisory Group Invests $792,000 in CVS Health Corporation $CVS

Net Worth Advisory Group acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) during the fourth quarter, HoldingsChannel reports. The fund acquired 9,985 shares of the pharmacy operator’s stock, valued at approximately $792,000.

Other large investors have also recently made changes to their positions in the company. SOA Wealth Advisors LLC. boosted its stake in shares of CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. Alteri Wealth LLC boosted its position in CVS Health by 3.2% during the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 131 shares during the period. Holistic Financial Partners grew its stake in shares of CVS Health by 4.1% during the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 133 shares during the last quarter. CYBER HORNET ETFs LLC increased its holdings in shares of CVS Health by 4.1% in the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 134 shares during the period. Finally, Fayez Sarofim & Co lifted its stake in shares of CVS Health by 2.1% in the 3rd quarter. Fayez Sarofim & Co now owns 6,913 shares of the pharmacy operator’s stock valued at $521,000 after acquiring an additional 140 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CVS has been the subject of several analyst reports. Barclays increased their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. The Goldman Sachs Group boosted their price objective on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Mizuho raised their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Stock Performance

NYSE:CVS opened at $70.08 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The firm’s fifty day simple moving average is $76.62 and its 200 day simple moving average is $77.77. The stock has a market cap of $89.16 billion, a P/E ratio of 50.79, a price-to-earnings-growth ratio of 0.73 and a beta of 0.49. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 annualized dividend and a yield of 3.8%. CVS Health’s dividend payout ratio (DPR) is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.